GNAO1-associated epileptic encephalopathy and movement disorders: c.607G> A variant represents a probable mutation hotspot with a distinct phenotype

被引:31
作者
Arya, Ravindra [1 ]
Spaeth, Christine [1 ,2 ]
Gilbert, Donald L. [3 ]
Leach, James L. [4 ]
Holland, Katherine D. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Comprehens Epilepsy Ctr, Div Neurol, Cincinnati, OH 45229 USA
[2] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA
[3] Cincinnati Childrens Hosp Med Ctr, Movement Disorders & Tourettes Syndrome Clin, Div Neurol, Cincinnati, OH 45229 USA
[4] Cincinnati Childrens Hosp Med Ctr, Div Pediat Neuroradiol, Cincinnati, OH 45229 USA
关键词
GNAO1; epileptic encephalopathy; epilepsy genetics; drugresistant epilepsy; chorea; GNAO1;
D O I
10.1684/epd.2017.0888
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe a case of GNAO1-associated epilepsy and chorea in a patient with a de novo pathogenic mutation. This patient is unique in being the first reported male with this phenotype, and we propose that this genetic variant may represent a mutation hotspot that characterizes a unique phenotype. This 5.2-years-old boy presented with seizures, chorea, and severe global developmental delay. Brain imaging showed progressive diffuse cerebral atrophy. EEG monitoring revealed multifocal and diffuse discharges, along with generalized-onset seizures. Genetic testing found a de novo pathogenic variant in the GNAO1 gene (c. 607G> A; p. Gly203Arg). A review of the literature showed two other patients with similar phenotype and the same genetic variant. In contrast, other patients with neurological involvement had private mutations in the GNAO1 gene. The neurological phenotypes associated with GNAO1 mutations appear to lie on a spectrum, and it is possible that the c. 607G> A (p. Gly203Arg) variant characterizes a phenotype with both severe epilepsy and chorea. [Published with video sequence on www. epilepticdisorders. com]
引用
收藏
页码:67 / 75
页数:9
相关论文
共 13 条
  • [1] De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies
    Appenzeller, Silke
    Balling, Rudi
    Barisic, Nina
    Baulac, Stephanie
    Caglayan, Hande
    Craiu, Dana
    De Jonghe, Peter
    Depienne, Christel
    Dimova, Petia
    Djemie, Tania
    Gormley, Padhraig
    Guerrini, Renzo
    Helbig, Ingo
    Hjalgrim, Helle
    Hoffman-Zacharska, Dorota
    Jaehn, Johanna
    Klein, Karl Martin
    Koeleman, Bobby
    Komarek, Vladimir
    Krause, Roland
    Kuhlenbaeumer, Gregor
    Leguern, Eric
    Lehesjoki, Anna-Elina
    Lemke, Johannes R.
    Lerche, Holger
    Linnankivi, Tarja
    Marini, Carla
    May, Patrick
    Moller, Rikke S.
    Muhle, Hiltrud
    Pal, Deb
    Palotie, Aarno
    Pendziwiat, Manuela
    Robbiano, Angela
    Roelens, Filip
    Rosenow, Felix
    Selmer, Kaja
    Serratosa, Jose M.
    Sisodiya, Sanjay
    Stephani, Ulrich
    Sterbova, Katalin
    Striano, Pasquale
    Suls, Arvid
    Talvik, Tiina
    von Spiczak, Sarah
    Weber, Yvonne
    Weckhuysen, Sarah
    Zara, Federico
    Abou-Khalil, Bassel
    Alldredge, Brian K.
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2014, 95 (04) : 360 - 370
  • [2] THE AGE-DEPENDENT EPILEPTIC ENCEPHALOPATHIES
    DONAT, JF
    [J]. JOURNAL OF CHILD NEUROLOGY, 1992, 7 (01) : 7 - 21
  • [3] Regulator of G Protein Signaling Protein Suppression of Gαo Protein-Mediated α2A Adrenergic Receptor Inhibition of Mouse Hippocampal CA3 Epileptiform Activity
    Goldenstein, Brianna L.
    Nelson, Brian W.
    Xu, Ke
    Luger, Elizabeth J.
    Pribula, Jacquline A.
    Wald, Jenna M.
    O'Shea, Lorraine A.
    Weinshenker, David
    Charbeneau, Raelene A.
    Huang, Xinyan
    Neubig, Richard R.
    Doze, Van A.
    [J]. MOLECULAR PHARMACOLOGY, 2009, 75 (05) : 1222 - 1230
  • [4] HUFF RM, 1985, J BIOL CHEM, V260, P864
  • [5] α2A adrenergic receptor activation inhibits epileptiform activity in the rat hippocampal CA3 region
    Jurgens, Chris W. D.
    Hammad, Hana M.
    Lichter, Jessica A.
    Boese, Sarah J.
    Nelson, Brian W.
    Goldenstein, Brianna L.
    Davis, Kylie L.
    Xu, Ke
    Hillman, Kristin L.
    Porter, James E.
    Doze, Van A.
    [J]. MOLECULAR PHARMACOLOGY, 2007, 71 (06) : 1572 - 1581
  • [6] Kito M, 1996, SEIZURE, V5, P115
  • [7] Progressive Movement Disorder in Brothers Carrying a GNAO1 Mutation Responsive to Deep Brain Stimulation
    Kulkarni, Neil
    Tang, Sha
    Bhardwaj, Ratan
    Bernes, Saunder
    Grebe, Theresa A.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2016, 31 (02) : 211 - 214
  • [8] Clinical whole-exome sequencing reveals a novel missense pathogenic variant of GNAO1 in a patient with infantile-onset epilepsy
    Law, Chun-Yiu
    Chang, Sharon Tzu-Lun
    Cho, Sun Young
    Yau, Eric Kin-Cheong
    Ng, Grace Sui-Fun
    Fong, Nai-Chung
    Lam, Ching-Wan
    [J]. CLINICA CHIMICA ACTA, 2015, 451 : 292 - 296
  • [9] GNAO1 encephalopathy: further delineation of a severe neurodevelopmental syndrome affecting females
    Marce-Grau, Anna
    Dalton, James
    Lopez-Pison, Javier
    Concepcion Garcia-Jimenez, Maria
    Monge-Galindo, Lorena
    Cuenca-Leon, Ester
    Giraldo, Jesus
    Macaya, Alfons
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [10] De Novo Mutations in GNAO1, Encoding a Gαo Subunit of Heterotrimeric G Proteins, Cause Epileptic Encephalopathy
    Nakamura, Kazuyuki
    Kodera, Hirofumi
    Akita, Tenpei
    Shiina, Masaaki
    Kato, Mitsuhiro
    Hoshino, Hideki
    Terashima, Hiroshi
    Osaka, Hitoshi
    Nakamura, Shinichi
    Tohyama, Jun
    Kumada, Tatsuro
    Furukawa, Tomonori
    Iwata, Satomi
    Shiihara, Takashi
    Kubota, Masaya
    Miyatake, Satoko
    Koshimizu, Eriko
    Nishiyama, Kiyomi
    Nakashima, Mitsuko
    Tsurusaki, Yoshinori
    Miyake, Noriko
    Hayasaka, Kiyoshi
    Ogata, Kazuhiro
    Fukuda, Atsuo
    Matsumoto, Naomichi
    Saitsu, Hirotomo
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2013, 93 (03) : 496 - 505